Successful Treatment of Imatinib-Induced DRESS Syndrome Using Reslizumab without Cessation of Imatinib: A Case Report

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction; reported cases are sometimes imatinib mesylate induced. The main treatment is the withdrawal of the causative drug, and most cases with imatinib-induced DRESS syndrome required withdrawal of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyerin, Choi, Gil-Soon, Lee, Eun Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613629/
https://www.ncbi.nlm.nih.gov/pubmed/34899250
http://dx.doi.org/10.1159/000519471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613629/
https://www.ncbi.nlm.nih.gov/pubmed/34899250
http://dx.doi.org/10.1159/000519471

Ejemplares similares